De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.
第一作者:
S,Jonas
第一单位:
Department of Surgery and Transplantation Medicine, Virchow Medical Center, Humboldt University Berlin, Germany.
作者:
医学主题词
抗体, 单克隆(Antibodies, Monoclonal);抗淋巴细胞血清(Antilymphocyte Serum);临床试验(主题)(Clinical Trials as Topic);环孢菌素(Cyclosporine);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肝移植(Liver Transplantation);淋巴瘤(Lymphoma);肿瘤, 继发原发性(Neoplasms, Second Primary);前瞻性研究(Prospective Studies);随机对照试验(主题)(Randomized Controlled Trials as Topic);受体, 白细胞介素2(Receptors, Interleukin-2);皮肤肿瘤(Skin Neoplasms);他罗利姆(Tacrolimus);宫颈肿瘤(Uterine Cervical Neoplasms);宫颈非典型增生(Uterine Cervical Dysplasia)
DOI
10.1002/(sici)1097-0142(19970915)80:6<1141::aid-cncr18>3.0.co;2-8
PMID
9305716
发布时间
2022-12-07
- 浏览28
Cancer
1141-50页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



